Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Co-Diagnostics to Sell up to 36K Tests to Medcis Pathlabs India

Co-Diagnostics to Sell up to 36K Tests to Medcis Pathlabs India

Sep 05, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Co-Diagnostics today announced Medcis Pathlabs India has agreed to purchase up to 36,000 of the company's tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Business News

  1. Roche Renews Agreement to Distribute Sysmex Hematology Products

  2. Rhinostics Licenses Procter & Gamble Nasal Swab for COVID-19 Testing

  3. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

  4. Bio-Rad, United Biomedical Get FDA Emergency Use Authorizations for Coronavirus Tests

  5. Lucira Health Files for $115M IPO

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.